Next time when you see those upside spikes is a chart, that is and extremely bullish sign. Maybe some insider buys! Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology that enables the functional selection of stem cells, and Quoin Pharmaceuticals Inc. (“Quoin”), a privately held specialty pharmaceutical company, today announced that...
The lower trend line has been very consistent on this stock, and until it breaks, this thing is a winner. Low float, high short interest, potential for huge gains. NASDAQ:APOP